Search Results

Return to List
Results 1–3 of 3
Title Date
1.

Aromatase Inhibitors in Gynecologic Practice

Number 663

(Replaces Committee Opinion Number 412, August 2008)

ABSTRACT Aromatase inhibitors have been used for the treatment of breast cancer ovulation induction endometriosis and other estrogenmodulated conditions For women with breast cancer bone mineral density screening is recommended with longterm aromatase inhibitor use because of risk of osteoporosis ...

June 2016

PDF Format
2.

Options for Prevention and Management of Heavy Menstrual Bleeding in Adolescent Patients Undergoing

Members Only

Number 606

August 2014

PDF Format
3.

The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer

Members Only

Number 659

March 2016

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998